LEADER 01351nam  2200385Ia 450 
001 9910696956103321
005 20230902162249.0
035   $a(CKB)5470000002383330
035   $a(OCoLC)549107096
035   $a(EXLCZ)995470000002383330
100   $a20100309d1999      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eaccelerated approval products, submission of promotional materials
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[1999]
215   $a1 online resource (i, 5 pages)
300   $a"Draft guidance."
300   $a"DDMAC#."
300   $a"March 1999."
517   $aGuidance for industry 
606   $aDrug approval$zUnited States
606   $aAdvertising$xDrugs$zUnited States
615  0$aDrug approval
615  0$aAdvertising$xDrugs
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696956103321
996   $aGuidance for industry$93434577
997   $aUNINA